Cat. No.: X23-10-ZQ416
JAK inhibitor SAR-20347, Purity ≥98%
Synonym: SAR-20347; 1450881-55-6; 2-(2-Chloro-6-fluorophenyl)-5-((4-(morpholine-4-carbonyl)phenyl)amino)oxazole-4-carboxamide; SAR20347; 2-(2-Chloro-6-fluorophenyl)-5-[[4-(4-morpholinylcarbonyl)phenyl]amino]-4-oxazolecarboxamide; 2-(2-Chloro-6-fluorophenyl)-5-[[4-(4-morpholinylcarbonyl)phenyl]amino]-4-oxazolecarboxamide; JAK inhibitor
- CAS Number: 1450881-55-6
- Compound CID: 71727668
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Properties
Description
SAR-20347, soluble in DMSO and insoluble in ethanol and water, is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1, JAK2, JAK3, and Tyk2.
Molecular Formula
C21H18ClFN4O4
Targets
JAK1: 23 nM; JAK2: 46 nM; JAK3: 41 nM; Tyk2: 0.6 nM
Solubility
DMSO: 77 mg/mL (173.09 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
SAR-20347 can be researched for its dual inhibition of JAK1 and Tyk2, with application in autoimmune disease models.
Related Products
-
JAK inhibitor JAK/HDAC-IN-1, Purity ≥98%
-
JAK inhibitor 1,2,3,4,5,6-Hexabromocyclohexane, Purity ≥98%
-
JAK inhibitor Abrocitinib, Purity ≥98%
-
JAK inhibitor AZ-3, Purity ≥98%
-
JAK inhibitor AZ-960, Purity ≥98%
-
JAK inhibitor AZD1480, Purity ≥98%
Quick Links